middle.news
Memphasys Nears Data Lock in Felix™ Trial, Eyes European Market Entry
10:05am on Tuesday 11th of February, 2025 AEDT
•
Biotechnology
Read Story
Memphasys Nears Data Lock in Felix™ Trial, Eyes European Market Entry
10:05am on Tuesday 11th of February, 2025 AEDT
Key Points
Last Patient Last Visit (LPLV) achieved, completing all patient data collection
Data lock anticipated in approximately two weeks following data verification
Preliminary trial results expected to be released in early March 2025
CE Mark submission underway to enable European market entry
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Memphasys (ASX:MEM)
OPEN ARTICLE